Dennis Thing
Analyst
SMICAP
Equibles does not estimate personal net worth.
About Dennis Thing
Dennis Thing is recorded as Analyst at SMICAP. Dennis Thing has spoken on 1 investor event across 1 company, most recently for Olema Pharmaceuticals, Inc. on June 3, 2026. The companies whose calls Dennis Thing spoke on are classified in the Healthcare sector.
Dennis Thing on recent calls
“I have the great pleasure of having Sean Bowen, CEO of Volima Pharmaceuticals, here. Welcome. Thank you, Dennis. What a time to, you know, to be alive in breast cancer, right?”
Affiliation history
-
SMICAP
Analyst
Transcript header (unverified)
Current